| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 253 | 2022 |
| Deciphering the state of immune silence in fatal COVID-19 patients P Bost, F De Sanctis, S Canè, S Ugel, K Donadello, M Castellucci, D Eyal, ... Nature communications 12 (1), 1428, 2021 | 117 | 2021 |
| The risk of dengue virus transmission in Dar es Salaam, Tanzania during an epidemic period of 2014 LEG Mboera, CN Mweya, SF Rumisha, PK Tungu, G Stanley, ... PLoS neglected tropical diseases 10 (1), e0004313, 2016 | 109 | 2016 |
| Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis MM Hellou, A Górska, F Mazzaferri, E Cremonini, E Gentilotti, P De Nardo, ... Clinical Microbiology and Infection 27 (3), 341-351, 2021 | 97 | 2021 |
| Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage P De Nardo, E Gentilotti, F Mazzaferri, E Cremonini, P Hansen, ... International Journal of Infectious Diseases 98, 494-500, 2020 | 79 | 2020 |
| Reliability and validity of using telephone calls for post-discharge surveillance of surgical site infection following caesarean section at a tertiary hospital in Tanzania B Nguhuni, P De Nardo, E Gentilotti, Z Chaula, C Damian, P Mencarini, ... Antimicrobial Resistance & Infection Control 6, 1-6, 2017 | 71 | 2017 |
| Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study P De Nardo, E Gentilotti, B Nguhuni, F Vairo, Z Chaula, E Nicastri, ... Journal of Hospital Infection 93 (4), 355-359, 2016 | 70 | 2016 |
| Clinical, virologic, and epidemiologic characteristics of dengue outbreak, Dar es Salaam, Tanzania, 2014 F Vairo, LEG Mboera, P De Nardo, NM Oriyo, S Meschi, SF Rumisha, ... Emerging infectious diseases 22 (5), 895, 2016 | 63 | 2016 |
| IgG against dengue virus in healthy blood donors, Zanzibar, Tanzania F Vairo, E Nicastri, SM Yussuf, A Cannas, S Meschi, MAA Mahmoud, ... Emerging infectious diseases 20 (3), 465, 2014 | 48 | 2014 |
| Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis E Gentilotti, P De Nardo, E Cremonini, A Górska, F Mazzaferri, ... Clinical Microbiology and Infection 28 (1), 13-22, 2022 | 46 | 2022 |
| Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine A Corpolongo, P De Nardo, P Ghirga, E Gentilotti, R Bellagamba, ... Malaria journal 11, 1-4, 2012 | 42 | 2012 |
| Haemolytic anaemia after oral artemether–lumefantrine treatment in a patient affected by severe imported falciparum malaria P De Nardo, A Oliva, ML Giancola, P Ghirga, P Mencarini, M Bibas, ... Infection 41, 863-865, 2013 | 34 | 2013 |
| HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania F Vairo, E Nicastri, G Liuzzi, Z Chaula, B Nguhuni, N Bevilacqua, F Forbici, ... BMC infectious diseases 13, 1-8, 2013 | 26 | 2013 |
| Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments A Gupta, A Konnova, M Smet, M Berkell, A Savoldi, M Morra, ... The Journal of clinical investigation 133 (6), 2023 | 25 | 2023 |
| Implementing a combined infection prevention and control with antimicrobial stewardship joint program to prevent caesarean section surgical site infections and antimicrobial … E Gentilotti, P De Nardo, B Nguhuni, A Piscini, C Damian, F Vairo, ... Antimicrobial Resistance & Infection Control 9, 1-11, 2020 | 24 | 2020 |
| Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort E Gentilotti, A Górska, A Tami, R Gusinow, M Mirandola, JR Baño, ... EClinicalMedicine 62, 2023 | 21 | 2023 |
| Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern F Mazzaferri, M Mirandola, A Savoldi, P De Nardo, M Morra, M Tebon, ... Elife 11, e79639, 2022 | 18 | 2022 |
| A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination P De Nardo, E Gentilotti, F Vairo, B Nguhuni, Z Chaula, E Nicastri, ... PloS one 13 (7), e0197996, 2018 | 18 | 2018 |
| Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors M Tempestilli, E Gentilotti, C Tommasi, E Nicastri, F Martini, P De Nardo, ... International Immunopharmacology 16 (4), 492-497, 2013 | 17 | 2013 |
| Total hip replacement infected with Mycobacterium tuberculosis complicated by Addison disease and psoas muscle abscess: a case report P De Nardo, A Corpolongo, A Conte, E Gentilotti, P Narciso Journal of Medical Case Reports 6, 1-5, 2012 | 17 | 2012 |
